Phillips Electronics North America Corp. has recalled 71 HeartStart MRx defibrillators produced in September and October 2016 due to a defect that may cause the device to fail, the Food and Drug Administration announced Friday. If used in automated external defibrillator mode after failing, the device will not delivery patient therapy, which may lead to serious patient injury or death, the agency said. For more information and a list of affected devices, see the FDA notice.

Related News Articles

Headline
The Centers for Disease Control and Prevention has partnered with Medscape to offer free online training on its recommendations for vaccinating homeless people…
Headline
The HPV vaccine could prevent an estimated 92% of cancers caused by the human papillomavirus in the United States, according to a new study by the Centers for…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will provide $23 million for Merck to produce…
Headline
The Food and Drug Administration yesterday approved a new antibiotic to treat adults with community-acquired bacterial pneumonia.
Headline
The number of U.S. hospitals with an antibiotic stewardship program that meets all core elements recommended by the Centers for Disease Control and Prevention…
Headline
The Centers for Medicare…